Request Deal Involvement
PerkinElmer completed the acquisition of BioLegend for $5.25bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
WilmerHale
legal advisors
McDermott Will & Emery
financial advisors
Goldman Sachs
legal advisors to financial advisors
Paul Weiss Rifkind Wharton & Garrison
debt providers
Goldman Sachs
financial advisors
JP Morgan
legal advisors
Pillsbury Winthrop Shaw Pittman
or
Principals
bidder
PERKINELMER INC
target
BIOLEGEND
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite